LivaNova PLC (LIVN): R&D Expense
$185.76M
Year ended 2025-12-31
$213.06M
Trailing 12 months to 2026-06-30
+6.0%
3-year compound annual growth
+4.0%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $185.76M | +1.8% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $182.51M | -5.8% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $193.82M | +24.4% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $155.81M | -15.1% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $183.41M | +20.0% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $152.90M | +4.1% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $146.85M | +0.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $145.95M | +33.3% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $109.52M | +33.4% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $82.08M | n/a | 2019-03-18, From 2016-01-01 |
| No annual figure between 2015-04-24 and 2016-12-31. | |||
| 2015-04-24 | $42.24M | -6.6% | 2018-02-28, From 2014-04-26 |
| 2014-04-25 | $45.22M | n/a | 2017-03-01, From 2013-04-27 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| LivaNova PLC (LIVN) | 2025-12-31 | $185.76M | +1.8% |
| Conmed Corp (CNMD) | 2025-12-31 | $55.88M | +2.7% |
| Integer Holdings Corp (ITGR) | 2025-12-31 | $49.50M | -7.3% |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $69.06M | +23.4% |
| InMode Ltd. (INMD) | 2025-12-31 | $13.32M | +1.4% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $32.88M | +18.4% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $21.23M | -44.7% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
Compare LIVN, CNMD, ITGR, TMDX side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗